BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
Crossref DOI link: https://doi.org/10.1186/s12885-015-1431-6
Published Online: 2015-05-27
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hayne, Dickon
Stockler, Martin
McCombie, Steve P.
Chalasani, Venu
Long, Anne
Martin, Andrew
Sengupta, Shomik
Davis, Ian D.
License valid from 2015-05-27